Cambridge Cognition Holdings Plc 1M7.F Stock
Cambridge Cognition Holdings Plc Price Chart
Cambridge Cognition Holdings Plc 1M7.F Financial and Trading Overview
Cambridge Cognition Holdings Plc stock price | 0.59 EUR |
Previous Close | 1.16 EUR |
Open | 1.16 EUR |
Bid | 1.14 EUR x N/A |
Ask | 1.23 EUR x N/A |
Day's Range | 1.16 - 1.16 EUR |
52 Week Range | 1.01 - 1.6 EUR |
Volume | 146 EUR |
Avg. Volume | 0 EUR |
Market Cap | 41.09M EUR |
Beta (5Y Monthly) | 1.055172 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.13 EUR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
1M7.F Valuation Measures
Enterprise Value | 27.77M EUR |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 3.2577946 |
Price/Book (mrq) | 386.66666 |
Enterprise Value/Revenue | 2.201 |
Enterprise Value/EBITDA | -53.091 |
Trading Information
Cambridge Cognition Holdings Plc Stock Price History
Beta (5Y Monthly) | 1.055172 |
52-Week Change | -16.54% |
S&P500 52-Week Change | 20.43% |
52 Week High | 1.6 EUR |
52 Week Low | 1.01 EUR |
50-Day Moving Average | 1.1 EUR |
200-Day Moving Average | 1.26 EUR |
1M7.F Share Statistics
Avg. Volume (3 month) | 0 EUR |
Avg. Daily Volume (10-Days) | 0 EUR |
Shares Outstanding | 34.82M |
Float | 22.52M |
Short Ratio | N/A |
% Held by Insiders | 24.42% |
% Held by Institutions | 29.57% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | December 31, 2022 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | -3.24% |
Operating Margin (ttm) | -4.89% |
Gross Margin | 73.90% |
EBITDA Margin | -4.14% |
Management Effectiveness
Return on Assets (ttm) | -2.79% |
Return on Equity (ttm) | -112.51% |
Income Statement
Revenue (ttm) | 12.61M EUR |
Revenue Per Share (ttm) | 0.41 EUR |
Quarterly Revenue Growth (yoy) | 20.39% |
Gross Profit (ttm) | N/A |
EBITDA | -523000 EUR |
Net Income Avi to Common (ttm) | -409000 EUR |
Diluted EPS (ttm) | -0.02 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 8.32M EUR |
Total Cash Per Share (mrq) | 0.27 EUR |
Total Debt (mrq) | 18K EUR |
Total Debt/Equity (mrq) | 18.95 EUR |
Current Ratio (mrq) | 0.896 |
Book Value Per Share (mrq) | 0.003 |
Cash Flow Statement
Operating Cash Flow (ttm) | 1.67M EUR |
Levered Free Cash Flow (ttm) | 2.92M EUR |
Profile of Cambridge Cognition Holdings Plc
Country | Germany |
State | N/A |
City | Cambridge |
Address | Tunbridge Court |
ZIP | CB25 9TU |
Phone | 44 1223 810 700 |
Website | https://www.cambridgecognition.com |
Industry | Health Information Services |
Sector(s) | Healthcare |
Full Time Employees | 80 |
Cambridge Cognition Holdings Plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB digital cognitive assessment platform for drug development by enabling pharmaceutical companies to take new therapeutics from preclinical consultancy to pivotal studies and approval, as well as supports sponsors to enhance recruitment, develop safe and effective treatments, and enhance research and development efficiency. It also provides CANTAB Connect Research, a proprietary platform that provides insights into behaviours, underlying brain circuits, and measurement of digital cognitive biomarkers; CANTAB Mobile, a touchscreen assessment of memory, mood, and functional status to detect the earliest signs of clinically relevant memory problems; CANTAB Insight to assess cognitive health; and CANTAB BrainHealth for assessing workplace wellbeing. In addition, the company offers electronic questionnaires and scales, a digital bespoke questionnaire; NeuroVocalix, a voice analysis platform to analyze voice to assess neurological change; cognition kit, a high frequency testing kit to detect changes over time and day-to-day cognition with short regular tests using patients' own devices. Cambridge Cognition Holdings Plc was incorporated in 2012 and is based in Cambridge, the United Kingdom.
Q&A For Cambridge Cognition Holdings Plc Stock
What is a current 1M7.F stock price?
Cambridge Cognition Holdings Plc 1M7.F stock price today per share is 0.59 EUR.
How to purchase Cambridge Cognition Holdings Plc stock?
You can buy 1M7.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Cambridge Cognition Holdings Plc?
The stock symbol or ticker of Cambridge Cognition Holdings Plc is 1M7.F.
Which industry does the Cambridge Cognition Holdings Plc company belong to?
The Cambridge Cognition Holdings Plc industry is Health Information Services.
How many shares does Cambridge Cognition Holdings Plc have in circulation?
The max supply of Cambridge Cognition Holdings Plc shares is 36.57M.
What is Cambridge Cognition Holdings Plc Price to Earnings Ratio (PE Ratio)?
Cambridge Cognition Holdings Plc PE Ratio is now.
What was Cambridge Cognition Holdings Plc earnings per share over the trailing 12 months (TTM)?
Cambridge Cognition Holdings Plc EPS is -0.13 EUR over the trailing 12 months.
Which sector does the Cambridge Cognition Holdings Plc company belong to?
The Cambridge Cognition Holdings Plc sector is Healthcare.